Roth Capital Affirms Regeneron (REGN) at 'Buy' Following Eylea Phase 2 Data in Wet-AMD Sep 30, 2016 10:16AM
Delcath Systems (DCTH) Prices ~$1.28M Common Stock, Warrants Offering Sep 30, 2016 09:23AM
Superior Drilling Products (SDPI) Prices 5M Share Offering at $1/Share Sep 30, 2016 08:30AM
Delcath Systems (DCTH) to Offer Common Stock and Warrants Sep 29, 2016 05:43PM
Notable Analyst Rating Changes 9/29: (OZM) (EBAY) (EMES) Upgraded; (AAPL) (FIT) (MANT) Downgraded Sep 29, 2016 10:25AM
View Older Stories

Sep 29, 2016 08:52AM Pre-Open Stock Movers 09/29: (AEGR) (ARWR) (EBAY) Higher; (ITCI) (ADHD) (FIT) Lower (more...)
Sep 29, 2016 08:17AM Actinium Pharma (ATNM) Prices 8M Common Stock Offering at $1.25/Share
Sep 29, 2016 07:05AM Roth Capital Starts CEVA Inc. (CEVA) at Buy
Sep 28, 2016 05:56PM After-Hours Stock Movers 09/28: (AEGR) (PIR) (GSAT) Higher; (ITCI) (ATNM) (PRGS) Lower (more...)
Sep 28, 2016 04:47PM Roth Capital Starts Ambarella (AMBA) at Buy
Sep 28, 2016 04:45PM Roth Capital Starts Magnachip Semiconductor (MX) at Buy
Sep 28, 2016 04:44PM Roth Capital Starts Silicon Motion Technology (SIMO) at Buy
Sep 28, 2016 04:43PM Roth Capital Starts Silicon Labs (SLAB) at Buy
Sep 28, 2016 04:42PM Roth Capital Starts Integrated Device Technology (IDTI) at Buy
Sep 28, 2016 04:41PM Roth Capital Starts Himax Technologies (HIMX) at Buy
Sep 28, 2016 08:41AM Roth Capital Downgrades Galectin Therapeutics (GALT) to Sell
Sep 27, 2016 02:10PM Roth Capital Reaffirms Actinium Pharma (ATNM) at 'Buy'; Says Starting Actimab-A Phase 2 is 'Important Step'
Sep 27, 2016 10:48AM Roth Capital Affirms Pieris Pharma (PIRS) at 'Buy' Following Positive PRS-343 Data
Sep 27, 2016 10:15AM Roth Capital Trims PT on Ligand Pharma (LGND) to $150 Amid New Kyprolis Data (AMGN)
Sep 27, 2016 07:54AM Roth Capital Keeps Ballard Power (BLDP) at 'Buy' Amid New Audi Orders
Sep 26, 2016 12:09PM Streetinsider.com's Hot Lunchtime Reads 9/26: (REGN) (ONTX) (LITE) (SFL)
Sep 26, 2016 11:16AM Roth Capital Reaffirms Regeneron (REGN) at 'Buy'; Dupilumab BLA in AD Key Next Step in Development
Sep 26, 2016 08:18AM Roth Capital Downgrades Digital Turbine (APPS) to Neutral
Sep 23, 2016 12:29PM Roth Capital Keeps BioLineRx (BLRX) at 'Buy' Amid New in-Licensing Agreement
Sep 23, 2016 07:48AM Roth Capital Starts Mindbody (MB) at Buy
Sep 23, 2016 07:23AM Roth Trims PT on Enphase Energy (ENPH) to $1.50 Amid Restructuring, Equity Offering
Sep 22, 2016 08:16AM Roth Capital Starts Fate Therapeutics (FATE) at Buy
Sep 22, 2016 08:15AM Roth Capital Assumes bluebird bio (BLUE) at Buy
Sep 21, 2016 12:13PM Streetinsider.com's Hot Lunchtime Reads 9/21: (LL) (RHT) (CUR) (TSLA)
Sep 21, 2016 11:56AM Roth Capital Affirms Neuralstem (CUR) at 'Buy' Amid NSI-189 Enrollment Milestone
Sep 20, 2016 02:29PM Roth Capital Reaffirms Palatin Technologies (PTN) at 'Buy'; Focus Now on BMT Phase III Data
Sep 20, 2016 12:22PM Roth Capital Reiterates Regeneron (REGN) at 'Buy' Following New Teva Pharma Ffasinumab Partnership
Sep 16, 2016 09:29AM Pre-Open Stock Movers 09/16: (DEPO) (INTC) (GPRO) Higher; (NVAX) (DB) (ORCL) Lower (more...)
Sep 16, 2016 09:01AM Capricor Therapeutics (CAPR) Prices 3M Common Stock Offering for Proceeds of ~$8.7M
Sep 16, 2016 08:45AM Roth Capital Starts Recro Pharma (REPH) at Buy
Sep 16, 2016 08:15AM Roth Capital Affirms S&W Seed (SANW) at 'Buy' Following Q4 Results; Says Margin Improvement Remains Key
Sep 16, 2016 06:28AM Callidus Software, Inc. (CALD) Prices 5.1M Common Stock Follow-on at $18.25/Share
Sep 15, 2016 07:16PM After-Hours Stock Movers 09/15: (SCOR) (CAR) (P) Higher; (NVAX) (DB) (ORCL) Lower (more...)
Sep 15, 2016 04:08PM Capricor Therapeutics (CAPR) Announces Common Stock Offering
Sep 15, 2016 04:05PM Capricor Therapeutics Announces Proposed Public Offering of Common Stock
Sep 15, 2016 10:27AM Notable Analyst Rating Changes 9/15: (GPN) (AKRX) (EXTR) Upgraded; (VFC) (FGP) (ATRA) Downgraded
Sep 15, 2016 09:30AM Pre-Open Stock Movers 09/15: (AERI) (ACRX) (NTWK) Higher; (SQNS) (PAH) (SRPT) Lower (more...)
Sep 15, 2016 08:49AM Roth Capital Downgrades Apigee (APIC) to Neutral
Sep 15, 2016 07:14AM Roth Capital Starts Sophiris Bio (SPHS) at Buy, $8 PT
Sep 14, 2016 04:01PM RGS Energy Completes $2.8 Million Public Offering of Preferred Stock and Warrants
Sep 14, 2016 12:26PM Roth Capital Positive on Heat Biologics (HTBX) as HS-110 Combo Phase 1b Enrollment Resumes
Sep 13, 2016 04:07PM Callidus Software, Inc. (CALD) to Offer 4M Common Shares
Sep 13, 2016 04:07PM CallidusCloud Announces Proposed Follow-On Offering
Sep 13, 2016 12:29PM Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' Following Initiation of LGD-6972 Phase 2 in T2D
Sep 13, 2016 09:00AM B. Riley & Co. Promotes Head of Capital Markets Andy Moore to President
Sep 13, 2016 08:28AM Roth Capital Downgrades Applied Genetic Technologies Corp. (AGTC) to Neutral
Sep 12, 2016 12:43PM Roth Capital Affirms Bioblast Pharma (ORPN) at 'Buy'; Extension Study Data Shows Sustainable Improvements
Sep 9, 2016 11:09AM Roth Remains Neutral on Peregrine Pharma (PPHM); Pipeline Advancing Well, but Catalysts Remain
Sep 9, 2016 09:17AM RGS Energy (RGSE) Prices Unit Offering for Proceeds of ~$2.2M
Sep 9, 2016 09:15AM RGS Energy Announces Pricing of Unit Offering
View Older Stories